Efficacy of combined low-dose ruxolitinib and cyclosporine in murine immune bone marrow failure

• Xingmin Feng,
• Ash Lee Manley,
• Zhijie Wu,
• Haoran Li,
• Shouguo Gao,
• Jibran Durrani,
• Nidhi Aggarwal,
• Hiroki Mizumaki,
• Jichun Chen,
• Neal S. Young,
• Emma M. Groarke

Affiliations

Xingmin Feng

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Ash Lee Manley

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Zhijie Wu

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Haoran Li

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Shouguo Gao

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Jibran Durrani

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Nidhi Aggarwal

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Hiroki Mizumaki

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Jichun Chen

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Neal S. Young

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Emma M. Groarke

Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD